Aktie A3C9NN EQRX, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen EQRx, Inc.

Aktien

A3C9NN

US26886C1071

EQRX

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Revolution Medicines Closes Acquisition of EQRx in All-Stock Deal
EQRx, Inc. Announces Board Resignations
EQRx, Inc.(NasdaqGM:EQRX) dropped from NASDAQ Composite Index
EQRx, Inc.(NasdaqGM:EQRX) dropped from S&P Global BMI Index
EQRx, Inc.(NasdaqGM:EQRX) dropped from S&P Biotechnology Select Industry Index
EQRx, Inc.(NasdaqGM:EQRX) dropped from S&P TMI Index
Revolution Medicines, Inc. completed the acquisition of EQRx, Inc. from a group of shareholders.
Revolution Medicines, EQRx Stockholders Approve Merger
Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition
EQRx, Inc.(NasdaqGM:EQRX) dropped from NASDAQ Biotechnology Index
EQRx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Calling All EQRx, Inc. (EQRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRX
EQRX Shareholder Investigation: Robbins LLP Reminds Shareholders it is Investigating EQRx, Inc. on behalf of Shareholders
EQRx, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Hansoh Pharmaceutical Terminates License Agreement With EQRx for Aumolertinib; Shares Slump 10%
EQRx : Termination of Material Agreement - Form 8-K
EQRx, Inc. Provides Written Notice to G1 Therapeutics of its Termination of the Exclusive License Agreement
EQRx, Inc. Provides Written Notice to Hansoh Healthtech Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Company Ltd. of Its Termination of the Strategic Collaboration License Agreement
EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRX
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3C9NN Aktie
  4. Nachrichten EQRx, Inc.
  5. Andere Sprachen